Blood–brain barrier: An impediment to neuropharmaceuticals

E-ISSN： 1532-6535|97|4|308-313

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.4, 2015-04, pp. : 308-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brain targeting PBCA nanoparticles and the blood––brain barrier

By Wilson B

Nanomedicine, Vol. 4, Iss. 5, 2009-07 ,pp. : 499-502

Future Medicine

Access to resources Recommend Favorite

Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics

Recent Patents on CNS Drug Discovery, Vol. 1, Iss. 2, 2006-01 ,pp. : 157-173

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals for assessing ABC transporters at the blood–brain barrier

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 362-371

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulation of ABC transporters at the blood–brain barrier

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 395-403

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disrupted vasculature and blood–brain barrier in Huntington disease

ANNALS OF NEUROLOGY, Vol. 78, Iss. 2, 2015-08 ,pp. : 158-159

John Wiley & Sons Inc

Access to resources Recommend Favorite